The Medical Cannabis Access Programme in Ireland currently provides access to cannabis to patients with one of three conditions when other treatments have not been successful. The three conditions are spasticity (stiff and/or rigid muscles) associated with multiple sclerosis, nausea and vomiting associated with chemotherapy, and severe epilepsy. This evidence review was conducted to […]
In this bulletin, data on deaths among people who were homeless and who died in 2020 are presented. The NDRDI collects data on all deaths among people who were homeless at the time of death, in order to improve understanding of premature mortality among people who are homeless nationally, and to provide more complete and […]
This report utilises a mixed-methods approach comprising both quantitative and qualitative tools to assess the outputs, outcomes and impacts of the TILDA programme. The methods used to collect data involved desk research (including bibliometric analysis), individual and focus group qualitative interviews, an in-depth organisational case study, and narrative analysis of TILDA’s outputs in various media. In […]
The purpose of this overview of reviews was to provide evidence to assist with the development of clinical guidelines on the primary prevention of dental caries in primary, permanent, and mixed dentition. Caries (dental decay) is a disease of the hard tissues of the teeth caused by an imbalance in this process over time, where […]
This year’s Health Research in Action highlights some of the many notable impacts and outcomes of the Health Research Board’s work. It includes a snapshot in numbers of our activity during 2022, followed by 29 success stories from our wide-ranging health and social care research portfolio. The stories include HRB-funded projects about examining healthcare complaints […]
Since May 2021, European Union member states were required to adopt a legislative stance on single use medical device (SUD) reprocessing i.e. a process including cleaning, disinfection, sterilisation and related procedures, as well as testing and restoring the technical and functional safety of the used device. The main objective of this review was to determine […]
Drugnet Ireland is the Health Research Board’s quarterly drug and alcohol research and policy newsletter. It provides summaries and analysis of recent publications and policy developments and well as overviews of particular issues relating to the drug and alcohol situation Ireland. Experts from the EMCDDA national focal point and from the HRB Evidence Centre contribute […]
Contents include: Chairperson and Chief Executive’s report; a snapshot of important HRB activities during 2022; key deliverables(in line with the HRB Strategy 2021-2025, Health research – making an impact) and Appendices. Part 2 contains the corporate governance and financial statements. This will be published later in 2023 once those accounts are approved by the Office […]
This is the annual, updated bulletin from the National Drug Treatment Reporting System (NDTRS) on cases of treated problem alcohol use in Ireland. This bulletin covers the period 2016 to 2022, in which 50,107 cases were treated for alcohol as a main problem during this seven-year period.
Experts from the EMCDDA national focal point and from the HRB Evidence Centre contribute content to the newsletter.Experts from the EMCDDA national focal point and from the HRB Evidence Centre contribute content to the newsletter.
Bulletin from the National Ability Supports System (NASS) on data provided by disability service providers for people engaging with services through the HSE disability budget in 2022.
The 2022 report provides data presented nationally as well as: – CHO – county – hospital type – individual psychiatric units/hospitals
The Census 2022 infographic and tables present findings from the eleventh national psychiatric census of patients in Irish psychiatric units and hospitals (IPUH). It is the latest in a series of censuses first carried out in 1963, and is a count of all patients resident in psychiatric units and hospitals operating within the provisions of […]
This is the annual, updated bulletin from the National Drug Treatment Reporting System (NDTRS) on cases of treated problem drug use (excluding alcohol) in Ireland. This bulletin includes a detailed summary of 12,009 cases treated for drug use as a main problem in 2022. Trends cover a seven-year period 2016 to 2022.
This feasibility study was commissioned by the Department of Health to address the need to improve understanding of premature mortality among people who are homeless nationally, and to provide more complete and accurate national data to inform policy. This retrospective review collates data on all deaths in persons categorised as homeless at time of death […]
Drugnet Ireland 84 insert.
Drugnet Ireland is the Health Research Board’s quarterly drug and alcohol research and policy newsletter. It provides summaries and analysis of recent publications and policy developments and well as overviews of particular issues relating to the drug and alcohol situation Ireland. Experts from the EMCDDA national focal point and from the HRB Evidence Centre contribute […]
This publication contains the 2021 corporate governance and financial statements of the Health Research Board, which have been approved by the Office of the Comptroller and Auditor General. Part one is also available for download (below), and contains the Chairperson and Chief Executive’s report; a snapshot of other important HRB activities in the year and key deliverables […]
This year’s Health Research in Action highlights some of the many notable impacts and outcomes of the Health Research Board’s work during 2021 across health and social care in Ireland, all of which made a real difference to people’s health, the health system, society, and the economy.
Community water fluoridation was introduced in Ireland in 1964 as a public health measure to prevent tooth decay. It is important for policymakers to keep up to date with the international research on the effects of community water fluoridation, so that the benefits and possible harms are known. In 2015, the Health Research Board’s Evidence […]
Drugnet Ireland is the Health Research Board’s quarterly drug and alcohol research and policy newsletter. It provides summaries and analysis of recent publications and policy developments and well as overviews of particular issues relating to the drug and alcohol situation Ireland. Experts from the EMCDDA national focal point and from the HRB Evidence Centre contribute […]
An integrative evidence review on service user participation in the design and delivery of drug treatment, recovery and harm reduction services
In this report, we present the results of a study that aimed to estimate the prevalence of problematic opioid use in Ireland from 2015 to 2019 using a four-source capture-recapture method. Three of the four data sources used for the analysis were derived from opioid substitution treatment records from the Central Treatment List (CTL) (clinics, […]
The 2021 report provides data presented nationally as well as: CHO county hospital type individual psychiatric units/hospitals
Drugnet Ireland is the Health Research Board’s quarterly drug and alcohol research and policy newsletter. It provides summaries and analysis of recent publications and policy developments and well as overviews of particular issues relating to the drug and alcohol situation Ireland. Experts from the EMCDDA national focal point and from the HRB Evidence Centre contribute […]
